期刊文献+

塞来昔布治疗类风湿性关节炎疗效观察 被引量:16

下载PDF
导出
摘要 目的探讨塞来昔布治疗类风湿性关节炎的疗效。方法将本院2009年12月~2010年6月收治的60例类风湿关节炎分为观察组和对照组。对照组采用常规治疗,观察组采用塞来昔布治疗。比较两组患者的临床疗效、关节疼痛指数、肿胀指数、握力、晨僵、血沉的变化及不良反应。结果观察组显效12例,有效9例,总有效率为70.0%显著高于对照组的50.0%,差异有统计学意义(P<0.05)。且观察组的关节疼痛指数、肿胀指数、握力、晨僵和血沉的改善显著优于对照组,差异有统计学意义(P<0.05)。观察组的不良反应显著少于对照组,差异有统计学意义(P<0.05)。结论塞来昔布治疗类风湿性关节炎疗效较好,且不良反应较少,值得临床推广。
作者 谭利民
出处 《中国医学创新》 CAS 2012年第1期37-38,共2页 Medical Innovation of China
  • 相关文献

参考文献6

二级参考文献21

  • 1毕会民,胡胜,甘佩珍.塞来考昔对女性卵巢功能的影响[J].中国新药与临床杂志,2004,23(8):538-539. 被引量:1
  • 2Zhao SZ, Mcmillen JI, Markenson JA, et al. Evaluation of the functional status aspects of Health-Related Quality of Life of patients with osteoarthritis treated with Celecoxib. Pharmacotherapy, 1999, 19(11): 1269-1278.
  • 3Zhao SZ, FiechtnerJJ, Tindall EA, et al. Evaluation of Health- Related Quality of Life of rheumatoid arthritis patients treated with Celecoxib. Arthritis Care and Research, 2000, 13(2): 112-121.
  • 4Becker MC, Wang TH, Wisniewski L, et al. Rationale, design, and governance of prospective randomized evaluation of Celecoxib inte- grated safety versus Ibuprofen or Naproxen (PRECISION), a cardio- vascular end point trial of nonsteroidal anti-inflammatory agents in patients with arthritis. Am Heart J, 2009, 157(4): 606-612.
  • 5Solomon SD, Wittes J, Finn PV, et al. Cardiovascular risk of Celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis. Circulatio, 2008, 117(16): 2104-2113.
  • 6Lelorier J, Fitzsimon C, Keresteci M, et al. Drug utilization review of Celecoxib in Ontario. Rheumatology, 2003, 42(suppl 3): 11-16.
  • 7Kvien TK. Epidemiology and burden of illness of rheumatoid arthritis. Pharmacoeconomics, 2004, 22(2 Suppl 1): 1-12.
  • 8Nivsrkar M. Improvement in circulating superoxide dismutase levels: Role of nonsteroidal anti-inflammatory drugs in rheumatoid arthritis biochemical and biophysical. Research Communications, 2000, 270(3): 714-716.
  • 9Niederberger E, Manderscheid C, Gr6sch S, et al. Effects of the se- lective COX-2 inhibitors celecoxib and rofecoxib on human vascular cells. Biochem Pharmacol, 2004, 68(2): 341-350.
  • 10Laine L, Connor LG, Reicin A, et al. Serious lower gastrointestinal clinical events with nonselective NSAID or Coxib Use. Gastroenterology, 2003, 124(2): 288-292.

共引文献103

同被引文献98

引证文献16

二级引证文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部